BACKGROUND: Children with average-risk acute lymphoblastic leukemia (AR-ALL) face many challenges that can adversely affect their quality of life (QOL). However, to the authors' knowledge, patterns and predictors of QOL impairment during therapy have not been well characterized to date. METHODS: Patients with AR-ALL who were enrolled on the Children's Oncology Group AALL0932 trial were offered participation in this prospective cohort study if they were aged 4 years at the time of diagnosis and had an English-speaking parent. At approximately 2 months, 8 months, 17 months, 26 months, and 38 months (boys only) after diagnosis, parents completed the Pediatric Quality of Life Inventory Generic Core Scales Version 4.0 (PedsQL4.0) and McMaster Family Assessment Device instruments for QOL (physical, emotional, and social functioning) and family functioning, respectively. The proportions of individuals scoring in the impaired range (2 standard deviations below the population mean) were calculated at each time point. Longitudinal impairment patterns and predictors were examined. RESULTS: A total of 594 participants with AR-ALL were diagnosed at a mean age of 6.0 years (standard deviation, 1.6 years). At 2 months, a substantial proportion of participants had impaired scores for physical (36.5%; 95% confidence interval [95% CI], 32.3%-40.8%) and emotional (26.2%; 95% CI, 22.5%-30.2%) functioning compared with population norms of 2.3%. These elevations persisted at 26 months. Emotional impairment at 2 months (odds ratio, 3.4; 95% CI, 1.5-7.7) was found to significantly predict emotional impairment at 26 months. In repeated measures analysis with multivariate modeling, unhealthy family functioning (odds ratio, 1.5; 95% CI, 1.1-2.1) significantly predicted emotional impairment controlling for age and sex. QOL outcomes were similar between sexes at the end of therapy (26 months for girls and 38 months for boys). CONCLU-SIONS: Many children with AR-ALL experience physical and emotional functioning impairment that begins early in treatment and persists. Early screening may identify high-risk patients who might benefit from family-based interventions. Cancer 2018;124:571-9.
INTRODUCTION
Acute lymphoblastic leukemia (ALL) accounts for approximately 25% of all childhood cancers. 1 With 5-year overall survival rates for ALL approaching and even exceeding 90% in some countries, health-related quality of life (QOL) has emerged as an important measure of successful treatment. 2 Many of the standard chemotherapy agents used to treat patients with ALL can affect both physical and psychosocial functioning. [3] [4] [5] Vincristine, methotrexate, and dexamethasone, all of which are common components of ALL treatment regimens, have been linked to peripheral neuropathy, neurocognitive deficits, and increased emotional and behavioral problems, respectively. [6] [7] [8] [9] Patients with ALL also face disruption to their QOL secondary to infection, unplanned and prolonged hospitalizations, and the fear of potential disease recurrence or death over a treatment period that lasts 2 to 3 years. 10 The frequent hospital visits and need to manage symptoms and painful procedures exact a toll not just on the patients but also on their caretakers. 11 Compared with parents of healthy children, parents of survivors of childhood leukemia were found to have greater symptoms of posttraumatic stress, with more symptoms associated with poor family functioning. 12 Poor or unhealthy family functioning, as defined by various clinical tools and constructs, is marked by high levels of conflict and disorganization, inadequate communication, and emotional dysregulation within the family unit. 13 In the United States, >90% of children diagnosed with leukemia each year are treated at a Children's Oncology Group (COG) member institution.
14 Analysis of health-related QOL outcomes on a previous COG ALL clinical trial demonstrated an increased frequency of anxiety/depression, and impaired physical and social functioning 2 months after treatment was completed. 15 However, these findings were derived from a single study of 160 participants. Unhealthy family functioning was identified as a possible risk factor but required confirmation with a larger sample. To inform future screening and interventions to reduce the burden of ALL therapy and improve QOL for patients and their families, the objectives of the current study were to: 1) describe the longitudinal patterns of physical, emotional, and social functioning with standardized instruments during ALL therapy in averagerisk patients; and 2) identify predictors associated with worse functioning.
MATERIALS AND METHODS

Study Population
The current study was a prospective cohort study of a subset of children enrolled in the COG interventional clinical trial AALL0932 at 157 COG member institutions. AALL0932 trial participants were offered this embedded study if they had average-risk B-cell ALL, were aged 4 years, had a parent who was fluent in English, and had no preexisting neurodevelopmental disorder (ie, Down syndrome, autism). Average-risk B-cell ALL in this protocol included the subset of National Cancer Institute standard-risk patients (initial white blood count <50,000/lL and age at diagnosis of 1.00-9.99 years) who also met the following criteria: no central nervous system 3 (ie, presence of leukemic blasts in cerebrospinal fluid sample that contains at least 5 white blood cells per microliter) or testicular leukemia, no Down syndrome, day 29 bone marrow minimal residual disease (MRD) < 0.01%, day 8 peripheral blood MRD < 1% for those with neither favorable nor unfavorable genetics, and day 8 peripheral blood MRD 0.1% or central nervous system 2 (ie, presence of leukemic blasts in cerebrospinal fluid sample that contains less than 5 white blood cells per microliter) for those with favorable genetics. 16 In total, 594 children were enrolled on this QOL study from centers in the United States, Canada, New Zealand, and Australia between August 2010 and April 2013. The Yale University Human Investigation Committee and individual institutional review boards of each participating site approved the current study. Informed consent and assent, when indicated, were obtained for all participants.
Procedure
Paper surveys for the current study were completed by parents at scheduled clinic appointments from early in therapy until the end of therapy at 2 months, 8 months, 18 months, 26 months, and 38 months (boys only) after the initial diagnosis. The end of therapy was 26 months for girls and 38 months for boys, which corresponded to 4 evaluations for girls and 5 for boys. Patients with recurrent or refractory disease or those who withdrew consent for the AALL0932 trial during the course of the study did not complete additional evaluations.
Measures
Measures in the current study were based on parent report. The primary outcome was impairment on the Pediatric Quality of Life Inventory Generic Core Scales Version 4.0 (PedsQL 4.0). The PedsQL 4.0 is a 23-item survey with responses on a 5-point Likert scale that measures a child's QOL. 17 It is reliable and valid in healthy pediatric populations, as well as in pediatric patients with cancer. [17] [18] [19] [20] We used a 1-month recall period and analyzed subscales for physical, emotional, and social functioning. As in previously published analyses of pediatric patients with cancer, impairment was defined as 2 standard deviations (SDs) below a healthy population mean. 15, 21 In terms of missing data, mean subscale imputation was performed if >50% of the items in a domain were answered; otherwise the score was not calculated as per the standardized instructions of the author of the scale.
Parents also completed the McMaster Family Assessment Device-General Functioning (FAD-GF) subscale at each time point to assess family functioning. The FAD-GF consists of 12 questions on a 4-point Likert scale with a validated mean cutoff score of >2.0 for unhealthy family functioning. 22 It has been shown to be valid and reliable in healthy populations, as well as medical and psychiatric samples. 23, 24 Scores were not calculated for any surveys missing 1 responses.
Parents completed a baseline demographic and family survey at the first time point only, which ascertained race/ethnicity, caregiver education, family income, and family structure.
Statistical Analysis
Participants were compared with nonparticipants in the larger clinical trial using the Kruskal-Wallis test for age at diagnosis and Fisher exact tests for sex and race. Participants who completed the final evaluations (26 months for girls and 38 months for boys) were compared with participants who did not using the Kruskal-Wallis test for age at diagnosis and Fisher exact tests for sex, race, family functioning at 2 months, and impairment on each of the PedsQL subscales at 2 months.
The proportions of participants scoring in an impaired range on the PedsQL, defined as worse than 2 SDs below normative means, were calculated for each time point for each subscale (physical, emotional, and social functioning). Logistic univariate regression taking into account repeated measures assessed the relationship between impairment on each subscale and the following independent variables: age at diagnosis, sex, race, Hispanic ethnicity, caregiver's marital status, family income (>50,000/year vs < $50,000/year), maternal education, household size (4 individuals vs > 4 individuals), pregnancy status (preterm vs full term), family functioning, any grade 3 adverse event, any grade 4 adverse event, any peripheral neuropathy (grade 3), and febrile neutropenia or infection (grade 3). The cutoff value of $50,000 per year for dichotomizing income was chosen because it most closely aligned with the US median income for families with children between 2010 and 2013, the years of study enrollment. 25 Grades 3 and 4 refer to the severity as set forth by the National Cancer Institute Common Terminology Criteria for Adverse Events (version 4.0), a standardized classification system that grades adverse effects. 26 Grade 3 generally refers to a severe condition compared with grade 4, which generally is defined as life-threatening.
Multivariate modeling, taking into account repeated measures of the outcome at multiple time points for each subscale, then was conducted for factors with a P value < .1 on the corresponding univariate analysis, as has been the convention in other QOL analyses. 15, 27 Fisher exact tests were performed to compare proportions impaired for each subscale (physical, emotional, and social functioning) between boys at 26 months versus girls at 26 months, as well as between boys and girls at the end of therapy (38 months and 26 months, respectively).
Univariate regression analyses were conducted to test association of impairment on each PedsQL subscale at earlier time points (ie, 2 months, 8 months, and 18 months) with impairment at 26 months (ie, the last time point that included data for both boys and girls).
All analyses were conducted using SAS statistical software (version 9.4; SAS Institute Inc, Cary, North Carolina). Table 1 shows the baseline patient and treatment characteristics of the study sample. A total of 594 children were diagnosed with average-risk ALL at a mean age of 6.0 6 1.6 years. There were slightly more boys than girls, and the cohort was predominantly white although 16% of the patients were Hispanic. A little more than one-half of the children lived in households in which the annual income was >$50,000. The majority of children had caregivers who were married and a mother who had completed some college or higher. Compared with patients with average-risk ALL who were enrolled in the AALL0932 trial who did not participate in this QOL study, a greater proportion of patients in this analysis were white (68% vs 55%; P<.01) and fewer were Hispanic (16% vs 24%). There was no difference noted in terms of sex. The completion rates of the PedsQL at each of the time points (2 months, 8 months, 18 months, 26 months, and 38 months) were 88% (519 patients), 77% (344 patients), 75% (325 patients), 70% (295 patients), and 60% (133 patients), respectively (see Supporting Information Fig. 1 ). When comparing participants who completed the final evaluation (26 months for girls and 38 months for boys) with those who did not, participants who completed the evaluation were more likely to be girls (66% vs 36%; P<.01) and less likely to have reported physical impairment on the PedsQL at 2 months (30% vs 40%; P 5 .04). They did not differ in terms of age at the time of diagnosis, sex, family functioning at 2 months, or emotional or social impairment at 2 months (all P>.2).
RESULTS
Participants
Rates of Impairment Figure 1 shows the proportions of patients with impaired scores in physical, emotional, and social functioning across the 5 time points. The expected population norm was 2.3% for the proportion impaired on each subscale. At 2 months after diagnosis, a substantial proportion of the participants had impaired scores for physical (36 Comparison by Sex Figure 2 shows the proportions of impairment at each time point stratified by sex. Compared with boys, girls were more likely to have emotional impairment at 2 months after diagnosis (P<.01). Boys were more likely than girls to have physical impairment at 17 months after diagnosis (P 5 .04). Otherwise, there were no differences noted between boys and girls. It is interesting to note that at 26 months, there were no statistical differences found between boys versus girls in any of the domains: physical (P 5 .47), emotional (P 5 1.00), or social (P 5 .34). At their respective end-of-therapy time points (ie, 38 months for boys and 26 months for girls), there were similarly no significant differences noted (all P>.2).
DISCUSSION
The current longitudinal, prospective analysis of QOL outcomes in children with ALL demonstrated that many of these patients experience considerable impairment in physical and emotional functioning during treatment.
Although the proportions of those impaired gradually improved over time, there remained a substantial subgroup of children who continued to exhibit difficulties in physical (11.9%) and emotional (9.8%) functioning even at 26 months after diagnosis. The current analyses demonstrated that early impairment predicted later impairment for both physical and emotional functioning and that patients with unhealthy family functioning were approximately 50% more likely to exhibit emotional impairment.
To our knowledge, this is the largest study to date on health-related QOL in children with ALL, which is the most common childhood malignancy. 3, 5, 15 The current analysis benefits from a longitudinal, prospective design that enabled us to characterize patterns and predictors of impairment over the course of treatment. In addition, the study was open at 157 COG member institutions (approximately 80% of all COG institutions with active institutional review board approval for the AALL0932 trial). In addition, although Hispanic patients were underrepresented compared with the larger clinical interventional trial (most likely due to the study eligibility requirement to have an English-speaking parent), approximately 15.7% of participants still were of Hispanic ethnicity. Diversity in socioeconomic status and maternal education also strengthened the generalizability of these findings. In addition, it is important to note that the traditional cutoff score on the PedsQL for "at-risk" QOL impairment is 1 SD below the population norm because it approximates those of children with severe chronic health conditions (including cancer). 18, 28 As in other studies of pediatric patients with cancer, we used the more rigorous cutoff of 2 SDs below the population norm to focus on individuals who were particularly vulnerable. 15, 21 Similar to our smaller analysis of children with standard-risk ALL enrolled in the COG AALL0331 trial between 2005 and 2009, we found that unhealthy family functioning was a significant predictor of impaired emotional functioning. 15 This result adds to a broad literature examining the relationships between childhood cancer diagnosis, parental stress, family adjustment, and QOL. 12, [29] [30] [31] Screening for family functioning can be quick and low cost; for example, the instrument used in the current study, the FAD-GF, is a short 12-question survey that can be easily administered in the clinic. 22 More importantly, family functioning is potentially modifiable with early intervention, as suggested by a series of promising studies in childhood cancer populations. [32] [33] [34] [35] [36] For example, Kazak et al found that a 1-day intervention combining cognitive behavioral therapy and family therapy approaches in adolescent cancer survivors and their parents led to increased cohesion and orderliness. 36 Other examples of early intervention strategies that have been piloted include problem-solving skills training for mothers of children newly diagnosed with cancer, and a stress management session for the parents of patients undergoing bone marrow transplantation. 32, 37 Each of these examples uses a targeted family-centered approach to psychosocial needs, underscoring the need for multidisciplinary care and the integration of embedded psychologists into the cancer treatment team. 38 The current study found that early impairment was a strong predictor of later impairment for physical and emotional functioning. Emotional functioning impairment was predictive starting at 2 months (the first time point), whereas physical functioning impairment was predictive starting at 8 months (the second time point). This is a novel result that was not found in the last COG analysis of health-related QOL in patients with ALL. 15 One of the major differences between the 2 studies is the timing of the first assessment, which was 1 month after diagnosis in the report by Mitchell et al 15 and closer to 2 months after diagnosis in the current study. It is possible that assessment so close to the initial diagnosis at 1 month does not have predictive value because it still reflects the acute toxicities of induction chemotherapy and/or the initial leukemia presentation. At 2 months after diagnosis, when some patients have potentially experienced an improvement in QOL, the impaired population may be more representative of those who will have persistent difficulties later during therapy. The larger size of the current study (>3 times that of the earlier sample) also likely provided more power with which to identify outcome predictors. These results provide a compelling rationale to screen patients for physical and emotional functioning early in therapy to target interventions toward patients at the highest risk of later impairment.
The trends in social functioning impairment differed from both physical and emotional functioning. In general, the rates of impairment remained within the range of the population norm, with a slight increase noted for both sexes at the end of therapy. A previous study examined children receiving chemotherapy for a heterogeneous group of cancer diagnoses and found that they actually performed better on several dimensions of social functioning compared with a control group of classroom peers. 39 The authors of that study posited that the cancer experience (ie, enduring painful procedures, chemotherapy side effects, and the possibility of death) may increase empathy and sensitivity in these patients, leading to better social functioning. They also suggested that enduring these challenges when many adults (eg, parents, teachers, health care team) are providing social support may help to build resilience. 39 Although the current study did not provide the data to explain the phenomenon of a rise in social impairment at the end of therapy, it may be related to a gradual reduction in the involvement of these built-in social support structures as treatment ends. From a developmental perspective, these patients are older at the end of treatment, when social demands and expectations are increased. 40 It is possible that gaps in social functioning become more apparent with a combination of reduced support and increased demands.
The current analysis also was able to examine sex and age effects on QOL impairment. Boys with ALL treated on COG clinical trials receive a longer duration of treatment. We did not find any statistical difference in the rates of QOL impairment between boys and girls as analyzed 2 ways: same elapsed time since diagnosis (at 26 months) and respective end of therapy time points (26 months for girls and 38 months for boys). In terms of age effects, children who were diagnosed at younger ages were found to be significantly more likely to exhibit emotional and social impairment. There is a growing body of literature that describes the effects of allostatic load on the developing brain. Nonnormative experiences such as illness can induce toxic stress, which causes permanent changes in brain structure and function that alter the child's response to future stressful experiences. 41, 42 Older children have experienced greater neuronal myelination of their limbic systems, which may mediate symptoms and the consequences of early-life stress. 43 The findings of the current study must be interpreted in light of certain limitations. Response rates dropped to 60% to 70% by the end of therapy. Attrition and missing data are a common problem in large studies of pediatric patients with chronic disease. 44 When comparing participants who completed the final evaluation versus those who did not, we found that girls and those with better physical functioning at 2 months were more likely to complete the final evaluation. Although we do not have the data to know exactly how this nondifferential response would affect our findings, it is possible that the current study underestimated the actual prevalence of QOL impairment at the end of therapy given the association between earlier and later physical impairment. Another potential limitation of the current study is that all outcomes were based on parent report, which may inaccurately estimate a child's QOL. 45 However, a structured review of QOL studies in children with ALL noted that children only begin to provide reliable responses around the age of 7 or 8 years, which would have been difficult with the current study sample given the children had a median age at the time of diagnosis of 5.7 years and an upper age limit of <10 years for enrollment in this clinical trial. 5 More importantly, it is recognized that parent report offers its own valid and complementary perspective on a child's QOL in conjunction with both the pediatric patient and their health care providers. 5 Based on the results of the current study, we conclude that significant proportions of children with ALL experience impaired physical and emotional functioning that begins early in treatment and persists. The current study data suggest that patients may benefit from the evaluation of QOL as early as 2 months after diagnosis to identify those at highest risk of later emotional impairment who could be targeted for early intervention strategies. In addition, family functioning is an important modifiable risk factor that may be targeted for early screening and intervention. 
